Page 5 - Janx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Janx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Janx Today - Breaking & Trending Today

Comparing Janux Therapeutics (NASDAQ:JANX) and VYNE Therapeutics (NASDAQ:VYNE)

Janux Therapeutics (NASDAQ:JANX – Get Free Report) and VYNE Therapeutics (NASDAQ:VYNE – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability and valuation. Volatility & Risk Janux Therapeutics has a […] ....

New Jersey , United States , San Diego , Immunomodulator Tracir , Therapeutics Inc , Janux Therapeutics Inc , Menlo Therapeutics Inc , Janux Therapeutics , Get Free Report , Tumor Activatedt Cell Engager , Tumor Activated Immunomodulator , Menlo Therapeutics , Janux Therapeutics Daily , Nasdaq Janx , Stock Comparison , Stock Analysis ,

Short Interest in Janux Therapeutics, Inc. (NASDAQ:JANX) Expands By 7.3%

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 2,940,000 shares, an increase of 7.3% from the April 15th total of 2,740,000 shares. Based on an average daily trading volume, of 69,500 shares, […] ....

United States , Janux Therapeutics Inc , Squarepoint Ops , Susquehanna International Group , Geode Capital Management , Janux Therapeutics , Get Rating , International Group , Street Corp , Capital Management , Therapeutics Stock Down , Tumor Activatedt Cell Engager , Janux Therapeutics Daily , Nasdaq Janx ,

Janux Therapeutics, Inc. (NASDAQ:JANX) Short Interest Update

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 2,940,000 shares, a growth of 7.3% from the April 15th total of 2,740,000 shares. Based on an average daily trading volume, of 69,500 shares, […] ....

United States , Tower Research Capital , Janux Therapeutics Inc , Barclays Plc , American International Group Inc , Sg Americas Securities , Janux Therapeutics Company Profile , Janux Therapeutics , Get Rating , Research Capital , American International Group , International Group , Tumor Activatedt Cell Engager , Janux Therapeutics Daily , Nasdaq Janx ,

Janux Therapeutics, Inc. (NASDAQ:JANX) Forecasted to Earn Q1 2024 Earnings of ($0.57) Per Share

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) – Equities researchers at HC Wainwright issued their Q1 2024 earnings estimates for Janux Therapeutics in a research report issued to clients and investors on Wednesday, May 10th. HC Wainwright analyst S. Ramakanth expects that the company will post earnings per share of ($0.57) for the quarter. HC […] ....

United States , Sg Americas Securities , American International Group Inc , Janux Therapeutics Inc , Tower Research Capital , Barclays Plc , Janux Therapeutics , Get Rating , Janux Therapeutic , Research Capital , American International Group , International Group , Tumor Activatedt Cell Engager , Janux Therapeutics Daily , Nasdaq Janx , Earnings Estimates , Hc Wainwright ,

Janux Therapeutics, Inc. (NASDAQ:JANX) Forecasted to Earn Q2 2023 Earnings of ($0.51) Per Share

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Rating) – Research analysts at HC Wainwright lifted their Q2 2023 earnings estimates for shares of Janux Therapeutics in a research report issued to clients and investors on Wednesday, May 10th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($0.51) per share for the quarter, […] ....

United States , Tower Research Capital , Barclays Plc , Janux Therapeutics Inc , Swiss National Bank , Janux Therapeutics , Get Rating , Janux Therapeutic , Therapeutics Stock Down , National Bank , Research Capital , State Teachers Retirement System , Tumor Activatedt Cell Engager , Janux Therapeutics Daily , Nasdaq Janx , Earnings Estimates , Hc Wainwright ,